首页> 美国卫生研究院文献>AAPS PharmSci >Chemical Potency and Degradation Products of Medications Stored Over 550 Earth Days at the International Space Station
【2h】

Chemical Potency and Degradation Products of Medications Stored Over 550 Earth Days at the International Space Station

机译:在国际空间站储存550天以上的药物的化学效力和降解产物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Medications degrade over time, and degradation is hastened by extreme storage conditions. Current procedures ensure that medications aboard the International Space Station (ISS) are restocked before their expiration dates, but resupply may not be possible on future long-duration exploration missions. For this reason, medications stored on the ISS were returned to Earth for analysis. This was an opportunistic, observational pilot-scale investigation to test the hypothesis that ISS-aging does not cause unusual degradation. Nine medications were analyzed for active pharmaceutical ingredient (API) content and degradant amounts; results were compared to 2012 United States Pharmacopeia (USP) requirements. The medications were two sleep aids, two antihistamines/decongestants, three pain relievers, an antidiarrheal, and an alertness medication. Because the samples were obtained opportunistically from unused medical supplies, each medication was available at only 1 time point and no control samples (samples aged for a similar period on Earth) were available. One medication met USP requirements 5 months after its expiration date. Four of the nine (44% of those tested) medications tested met USP requirements 8 months post expiration. Another three medications (33%) met USP guidelines 2–3 months before expiration. One compound, a dietary supplement used as a sleep aid, failed to meet USP requirements at 11 months post expiration. No unusual degradation products were identified. Limited, evidence-based extension of medication shelf-lives may be possible and would be useful in preparation for lengthy exploration missions. Only analysis of flight-aged samples compared to appropriately matched ground controls will permit determination of the spaceflight environment on medication stability.Electronic supplementary materialThe online version of this article (doi:10.1208/s12248-015-9834-5) contains supplementary material, which is available to authorized users.
机译:药物会随着时间推移而降解,极端的储存条件会加速降解。当前的程序可确保国际空间站(ISS)上的药物在过期之前重新存放,但在将来的长期探索任务中可能无法补给。因此,储存在国际空间站的药物被送回地球进行分析。这是一个机会主义的,观察性的中试规模调查,目的是检验ISS老化不会引起异常降解的假设。分析了九种药物的活性药物成分(API)含量和降解量;将结果与2012年美国药典(USP)要求进行比较。这些药物是两种助眠药,两种抗组胺药/减充血药,三种止痛药,止泻药和警觉性药物。由于样品是从未使用的医疗用品中偶然获得的,因此每种药物只能在1个时间点获得,并且没有对照样品(在地球上处于类似时期的样品)。一种药物在有效期满5个月后符合USP要求。九种药物中有四种(占被测药物的44%)在过期后8个月达到USP要求。另三种药物(33%)在过期前2-3个月符合USP准则。一种化合物(用作膳食补充剂的睡眠辅助剂)在过期后11个月未达到USP要求。没有发现异常降解产物。有限的,循证的延长药物的保质期是可能的,这对于准备进行漫长的勘探任务很有用。仅对飞行时间样本进行分析并与适当匹配的地面控制器进行比较,才能确定航天环境对药物稳定性的影响。电子补充材料本文的在线版本(doi:10.1208 / s12248-015-9834-5)包含补充材料,其中适用于授权用户。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号